Find Academic Supervisors

Camila AquinoView profile

Assistant Professor

• Movement Disorders
• Parkinson's Disease
• Deep Brain Stimulation
• +5 more

Dr. Camila Aquino serves as Assistant Professor in both the Department of Clinical Neurosciences and Department of Community Health Sciences at the University of Calgary's Cumming School of Medicine, and is a Full Member of the Hotchkiss Brain Institute. As Medical Director of the Deep Brain Stimulation Program, she specializes in Parkinson's disease, essential tremor, dystonia, and chorea management, including EMG-guided botulinum toxin injections. Her educational background includes: M.D. in Medicine from Escola Superior de Ciencias da Santa Casa (2005) M.S. in Neurosciences from Federal University of Sao Paulo (2012) Ph.D. in Neurosciences from Federal University of Sao Paulo (2019) M.S. in Health Research Methods, Clinical Epidemiology from McMaster University (2020) Dr. Aquino's research addresses unmet needs in movement disorders through innovative clinical trial designs for Parkinson's disease, focusing on precision-medicine approaches, early intervention, and outcome optimization. She actively evaluates neuromodulation therapies including Deep Brain Stimulation, Spinal Cord Stimulation, and MRgFUS, with emphasis on expanding indications and improving patient outcomes. As an International Parkinson and Movement Disorder Society member, she chairs the web-based learning committee and serves on evidence-based medicine and outcome measure committees. Analysis of her 15 most recent publications (2021-2025) reveals a cohesive research trajectory centered on Parkinson's disease management, with dominant themes in motor fluctuation treatments, deep brain stimulation methodology, and clinical trial innovation. Her work bridges fundamental clinical practice guidelines with advanced neuromodulation technologies, demonstrating consistent commitment to evidence-based solutions for movement disorders. Her scientific recognition includes: Parkinson Canada research grant Mohammed Al Zaibak Foundation scholarship CAPES scholarship from Brazilian Ministry of Education Dr. Aquino has secured significant research funding supporting clinical trials in Parkinson's disease neuroprotection and neuromodulation therapies. While specific student advisees aren't listed, her leadership of the DBS Program and active clinical trial portfolio indicate substantial mentorship responsibilities. Her grant portfolio emphasizes translational research with direct clinical impact. She directs the University of Calgary's Deep Brain Stimulation Program and contributes to the MRI-guided focused ultrasound initiative. Through her International Parkinson and Movement Disorder Society committee roles, she shapes global educational standards and evidence-based practices in movement disorders.

Maria CraigView profile

Professor

• Childhood Diabetes
• Type 1 Diabetes
• Virology and Diabetes
• +4 more

Professor Maria Craig is a distinguished academic and researcher at the University of New South Wales, Faculty of Medicine & Health, specializing in childhood diabetes research. She holds a prominent position as a Professor with extensive contributions to the field of pediatric endocrinology and diabetes, particularly focusing on type 1 diabetes in children. Professor Craig's educational background includes: MB BS from the University of Melbourne MMedSc(ClinEpid) from the University of Newcastle PhD from the University of Sydney FRACP (Fellow of the Royal Australasian College of Physicians) Professor Craig's research primarily focuses on childhood diabetes, with special emphasis on prediction and prevention of type 1 diabetes. She has a significant interest in the association between viruses and type 1 diabetes, collaborating with the Virology Research Group at Prince of Wales Hospital (POWH). Together with Professor Bill Rawlinson, she leads the viral theme for the multicentre ENDIA study (endia.org.au). As principal investigator for the CoRD trial, she is conducting a world-first phase 1 study using autologous cord blood for prevention of type 1 diabetes in children with islet autoimmunity. Additionally, she serves as principal investigator for the Australasian Diabetes Data Network (ADDN). Her research portfolio also encompasses the epidemiology of various forms of childhood diabetes (type 1, type 2, cystic fibrosis related diabetes and monogenic diabetes) and diabetes complications, in collaboration with Professor Kim Donaghue at the Children's Hospital at Westmead. Professor Craig's extensive publication record, including over 361 journal articles, demonstrates her leadership in advancing our understanding of childhood diabetes. Her recent work shows increasing focus on early detection methods, risk prediction models, technological interventions for diabetes management, and the complex interplay between viral infections and autoimmune diabetes development. She has been instrumental in developing clinical practice guidelines through her role as co-editor of the International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines. Professor Craig has received numerous prestigious awards recognizing her contributions to pediatric endocrinology and diabetes research: Australian Paediatric Endocrine Group Young Investigator's Award (1997) Asia Pacific Paediatric Endocrine Society Clinical Teaching Award (2008) Lifetime Honorary Member, Caring and Living as Neighbours (2013) Australian Diabetes Society Jeff Flack Diabetes Data Award (2019) Australian Paediatric Endocrine Group Norman Wettenhall Award for Research and Innovation (2019) Throughout her career, Professor Craig has demonstrated exceptional leadership in professional societies, having served as former president/treasurer of the Australasian Paediatric Endocrine Group (APEG) and currently as Scientific Convenor of the Asia Pacific Paediatric Endocrine Society Fellows school. Her work with the ENDIA study and Australasian Diabetes Data Network represents significant collaborative research efforts involving multiple institutions across Australia and internationally. Her principal investigator roles for major studies indicate substantial research funding support. Professor Craig leads several important research initiatives including the ENDIA study, the CoRD trial, and the Australasian Diabetes Data Network. These programs involve multidisciplinary teams of researchers, clinicians, and support staff working collaboratively to advance understanding and treatment of childhood diabetes. Her work at the intersection of virology and diabetes represents a unique and innovative approach to understanding the environmental triggers of type 1 diabetes.

Michael A OsborneView profile

Professor

• Machine Learning
• Bayesian Optimization
• Gaussian Processes
• +3 more

Michael A Osborne is Professor of Machine Learning at the University of Oxford and leads the Bayesian Exploration Lab . He serves as Director of the EPSRC Centre for Doctoral Training in Autonomous Intelligent Machines and Systems and co-directs the Oxford Martin AI Governance Initiative. His research focuses on Bayesian optimization, Gaussian processes, and probabilistic numerics with applications in quantum devices, battery modeling, and AI governance. Key Positions: Professor of Machine Learning, University of Oxford Official Fellow, Exeter College Co-founder of Mind Foundry Lead Researcher, Oxford Martin Programme on Technology and Employment Research Themes: Probabilistic modeling for quantum systems Uncertainty quantification in energy storage AI safety and societal impact analysis Automated experimental design Quantum device calibration Probabilistic numerical methods Technical Contributions: Bridging reality gap in quantum devices Efficient Bayesian quadrature techniques Personalized neurostimulation algorithms Automated measurement protocols Quantum-classical hybrid ML

John OakeyView profile

Professor

• Microfluidics
• Microscale transport phenomena
• Tissue engineering and regenerative medicine
• +4 more

John Oakey is a Professor and Graduate Coordinator in the Department of Chemical and Biomedical Engineering at the University of Wyoming, with additional affiliations to the INBRE Program, Molecular and Cellular Life Sciences Program, and Materials Science and Engineering Program. Education Postdoctoral Fellow, Center for Engineering in Medicine, Massachusetts General Hospital & Harvard Medical School (2007–2010) Ph.D. Chemical Engineering, Colorado School of Mines (2003) M.S. Chemical Engineering, Colorado School of Mines (1999) B.S. Chemical Engineering, Penn State University (1997) Research Interests Oakey’s laboratory integrates fluid dynamics, colloidal science and materials science to understand how biological systems behave under flow, on surfaces and within complex 3-D geometries. A unifying theme is the use of microfabrication and microfluidics to create new diagnostic, prognostic and therapeutic platforms. Current thrusts include: Heterogeneous biomaterials: self-assembled particulate tissue scaffolds whose mechanical and transport properties can be temporally programmed. Inertial microfluidics: exploiting lift forces for membrane-free particle sorting, enrichment and diagnostics. Multi-temporal analysis by flow cytometry: development of closed-loop, high-throughput microfluidic cytometers for longitudinal single-cell studies. Publication Trends From 2025 back to 2010, Oakey’s articles reveal a consistent trajectory that marries fundamental physics (microtubule mechanics, inertial focusing) with translational applications (cell encapsulation, tissue scaffolds, drug delivery). Recent work (2023-2025) increasingly targets injectable granular hydrogels, single-cell therapeutic delivery and sustainable carbon-sequestering living materials, demonstrating an evolution from microscale transport phenomena to macroscopic biomedical and environmental impact. Scientific Awards No named awards are listed in the supplied text. Advising & Coordination Roles As Graduate Coordinator for the Department of Chemical and Biomedical Engineering, Professor Oakey oversees graduate program development and student mentoring. While no individual students are named, his role implies active supervision of M.S. and Ph.D. advisees in chemical and biomedical engineering. Laboratory & Teams The Oakey Research Group operates from the Energy and Environmental Research Building (EERB 435A) at the University of Wyoming. The lab enjoys R1-level research infrastructure and collaborates broadly with the Wyoming INBRE network, the Molecular and Cellular Life Sciences Program, and the Materials Science and Engineering Program.

• Gynecologic Oncology
• Ovarian Cancer
• Breast Cancer
• +5 more

Federica Tomao is an Associate Professor at the Department of Maternal, Child and Urological Sciences within Sapienza University of Rome. She actively teaches and supervises courses in Medicine and Surgery , Nursing , and Midwifery programs across multiple institutions. Current faculty member with academic rank Teaching roles in 6th, 3rd, and 2nd year courses Specialized in gynecologic oncology Research Focus : Her work spans ovarian cancer, breast cancer, and endometrial cancer, emphasizing chemotherapy optimization, precision medicine, and radiomics. Notably, she contributes to understanding PARP inhibitors, immune checkpoint therapies, and fertility preservation techniques in cancer survivors. Recent Publications highlight advancements in sarcopenia analysis, BRCA testing, and radiogenomic nomograms. These studies demonstrate her commitment to bridging imaging and molecular data for improved cancer management. Email : federica.tomao@uniroma1.it

Yannis PaschalidisView profile

Professor

• Optimization
• Control Systems
• Stochastic Systems
• +8 more

Yannis Paschalidis is a Distinguished Professor at Boston University with appointments in Electrical and Computer Engineering, Systems Engineering, Biomedical Engineering, and Computing & Data Sciences. He serves as Director of the Rafik B. Hariri Institute for Computing and Computational Science & Engineering. He holds a PhD (1996) and MS (1993) in Electrical Engineering and Computer Science from MIT, and a Diploma (1991) from the National Technical University of Athens. His interdisciplinary research spans optimization, control systems, machine learning, and data science with applications in healthcare, autonomous systems, and networks. Key focus areas include developing algorithms for autonomous navigation, healthcare analytics for clinical decision support, energy demand optimization, and computational biology for protein interaction modeling. Recent publications demonstrate strong focus on AI robustness (adversarial defenses, distributional robustness), healthcare applications (cognitive impairment detection, epidemic control), and sustainable systems (power networks, ecological forecasting). Methodological innovations center on reinforcement learning, distributionally robust optimization, and geometric analysis of classical algorithms. CAREER Award (NSF) IEEE Fellow (2014) IFAC Fellow (2022) IBM/IEEE Smarter Planet Award IEEE Computer Society Crowd Sourcing Prize IMIA Best Paper Award Charles DeLisi Award (2020) Distinguished Professor of Engineering As primary advisor to 35 PhD graduates, he leads the Network Optimization & Control (NOC) Lab. His research is funded by NSF, NIH, DoD, ARPA-E, and industry partners, including major grants on Neuro-Autonomy (ONR MURI), pandemic preparedness (ARPA-E NewRAMP), and healthcare AI (NIH QuBBD). He directs the Network Optimization & Control Lab focusing on optimization, learning, and control for autonomous systems, healthcare, and networks. The lab develops fundamental methodologies with applications in robotics, computational medicine, and infrastructure systems.

Aleksandar JeremicView profile

Associate Professor

• Biomedical Signal Processing
• Statistical Signal Processing
• Biometrics
• +7 more

Aleksandar Jeremic is an Associate Professor in both the Electrical & Computer Engineering department and the McMaster School of Biomedical Engineering at McMaster University. His research focuses on biomedical signal processing, statistical signal processing, and biometrics, with applications in healthcare and biomedical systems. He holds a Dipl. Ing. from the University of Belgrade, and an M.S. and Ph.D. from the University of Illinois at Chicago. His expertise spans physiological signal analysis (e.g., ECG/EEG), medical imaging, and machine learning for biomedical applications. He has authored over 50 technical articles and two book chapters, and has been recognized with a teaching award from the McMaster Electrical and Computer Engineering Society (2018). He supervises graduate students in both theoretical and applied research areas. Dr. Jeremic teaches advanced courses such as Biomedical Signal Modeling and Processing and Advanced Probability and Random Processes , emphasizing practical applications of signal processing in healthcare. His work includes clinical implementations like neonatal seizure monitoring software and microwave imaging for breast cancer detection.

• Lymphoma
• Hodgkin Lymphoma
• Non-Hodgkin Lymphoma
• +5 more

Jonathan W. Friedberg, M.D., M.M.Sc. is the Director of the Wilmot Cancer Institute and Professor in the Department of Medicine, Hematology/Oncology at the University of Rochester School of Medicine and Dentistry. He holds the Samuel E. Durand Chair in Medicine and leads one of the nation's premier lymphoma programs. Dr. Friedberg is internationally recognized for his expertise in lymphoma treatment, particularly in developing novel therapies and clinical trial approaches. Dr. Friedberg's research focuses on lymphoma, with particular expertise in Hodgkin lymphoma, non-Hodgkin lymphoma, Waldenstrom macroglobulinemia, and chronic lymphocytic leukemia. His work spans the entire treatment continuum from diagnosis through novel therapies including autologous stem cell transplantation and CAR-T cell interventions. He has built a comprehensive lymphoma program with expertise spanning hematopathology, radiation oncology, dermatology, and neurology, in addition to hematology and medical oncology. His research interests include developing risk-adapted treatment strategies, investigating novel therapeutic agents, and improving outcomes for patients with various lymphoma subtypes. Dr. Friedberg's extensive publication record demonstrates his leadership in lymphoma research, with recent work focusing on immunotherapy combinations, predictive modeling, risk stratification, and novel treatment approaches for various lymphoma subtypes. His research has significantly contributed to the understanding and treatment of lymphomas, particularly in developing more personalized and effective treatment strategies. Scientific Awards: Faculty Academic Mentoring Award (2012) Scholar in Clinical Research (2008) America's Top Doctors Selection (2008) Jacob Gitelman Award (2007) Lawrence A. Kohn Senior Teaching Fellow (2004-2006) Clinical Investigator Career Development Award (2003) Clinical Oncology Research Fellowship "Immunotherapy of Hodgkin's Disease" (2001-2003) Rising stars program for innovative research (2001-2003) As Director of the Wilmot Cancer Institute, Dr. Friedberg leads numerous clinical trials and research initiatives focused on advancing lymphoma treatment. He is actively involved in SWOG and has served in leadership roles for multiple clinical trials investigating novel therapies for lymphoma patients. His practice team includes Anna Morrison, R.N., and Kerri Hugelmaier, N.P., providing comprehensive care for lymphoma patients. Dr. Friedberg has established the Lymphoma Epidemiology of Outcomes (LEO) Consortium, a large observational cohort study supporting broad research on NHL prognosis and survivorship. His leadership extends to national organizations where he contributes to developing clinical practice guidelines and consensus recommendations for lymphoma treatment.

• Pulmonary vasculature
• Heart Failure
• Cardiopulmonary Immunology

Michael Yeager, PhD, serves as an Associate Clinical Professor in the School of Medicine at the University of Colorado Denver, focusing on cardiopulmonary pathophysiology with emphasis on pulmonary hypertension and heart failure mechanisms. He completed his PhD at the University of Colorado Health Sciences Center in 2002, establishing foundational expertise in vascular biology. His research program investigates immunological and molecular drivers of pulmonary vascular disease, particularly the roles of autoantibodies, fibrocytes, and inflammatory cascades in disease progression. Analysis of his 14 publications (2012-2015) reveals consistent exploration of biomarker discovery, vascular remodeling, and immune dysregulation across pediatric and adult pulmonary hypertension. Key methodological approaches include proteomics, animal modeling, and molecular interrogation of cellular stress responses, with significant translational implications for personalized therapeutic strategies. Professional recognitions include: Outstanding Faculty award from Tau Beta Pi (2019) Chancellor's Teaching Recognition Award from the University of Colorado (2016) Dr. Yeager maintains active clinical research collaborations at Children's Hospital Colorado while mentoring within the medical school curriculum. His work bridges basic science discovery with clinical application through ongoing investigations into endothelial dysfunction and inflammatory mediators. Affiliated with the Department of Medicine, he contributes to pulmonary vascular research initiatives and participates in professional societies including the American Thoracic Society, American Heart Association, and T21 Research Society.

• RNA Biology
• Myeloid Malignancies
• Hematology
• +4 more

Dr. Giulia Biancon is an Assistant Professor Adjunct in the Department of Medical Oncology and Hematology at Yale School of Medicine. She holds a PhD from the University of Milan (2019) and is a member of the Halene Lab, focusing on RNA biology and hematologic malignancies. Her research combines high-throughput methodologies to study RNA mechanisms in diseases like myeloid leukemias and splicing factor mutations. Education: PhD in Molecular Biology from the University of Milan (2019). Research Interests: RNA splicing, stress granules in cancer, epitranscriptomics, clonal hematopoiesis, and the interplay between genetic mutations and cellular pathways in blood cancers. Awards: 2024 Eclipse Award, 2022 ASH Abstract Achievement Award, and 2022 RNA Society Best Poster Award. Her work has been published in journals like Cell Reports , Blood , and Molecular Cell . Labs/Teams: Principal member of the Halene Lab and coordinator at the Yale Center for RNA Science and Medicine. Collaborates with institutions like the SeroNet network for immunology studies.

Ceren BudakView profile

Associate Professor

• Computational Social Science
• Social Media Analysis
• News Media Production and Consumption
• +7 more

Ceren Budak is an Associate Professor at the University of Michigan School of Information and holds a joint appointment as Associate Professor of Electrical Engineering and Computer Science in the College of Engineering. Her work bridges computer science, statistics, and social sciences through computational social science approaches. Her educational background includes a PhD in Computer Science from the University of California, Santa Barbara (2012) and a Bachelors degree in Computer Science from Bilkent University in Turkey (2007). Prior to joining the University of Michigan faculty, she was a Postdoctoral Researcher at Microsoft Research New York. Professor Budak's research centers on computational social science, with particular emphasis on analyzing large-scale datasets to address questions with social, political, and policy implications. Her work spans several interconnected domains: News Media Production & Consumption (examining bias in news outlets and reader preferences), Social Movements & Media (using social media data to study collective action), Social Networks (understanding information diffusion processes), and Measuring and Promoting the Quality of Online Discussions (developing tools to improve online conversations). She teaches SI 608 (Networks) and SI 618 (Data Manipulation and Analysis) at the School of Information. Her publication record demonstrates consistent contributions to understanding how online information ecosystems operate, with recent work focusing on AI-human collaboration, misinformation dynamics, social movement framing, and the application of computational methods to political communication. Her research shows a clear trajectory from foundational work on social network diffusion to increasingly sophisticated analyses of contemporary information challenges. Among her service activities, she has served as Registration chair for COSN (ACM Conference on Online Social Networks) 2015 and as Program Committee Member for numerous prestigious conferences including WWW, ICWSM, WebSci, AAAI, and others. She has also been involved in organizing the MSR NYC Data Science Seminar Series and instructing the Microsoft Research Data Science Summer School.

Michael MoorView profile

Assistant Professor

• Medical AI
• Machine Learning in Healthcare
• Causal Learning
• +3 more

Prof. Michael Moor is a tenure-track Assistant Professor for Medical AI at ETH Zurich's Department of Biosystems Science and Engineering in Basel. Previously, he conducted postdoctoral research at Stanford University under Prof. Jure Leskovec, focusing on medical foundation models. His work spans causal learning, multimodal AI, and sepsis prediction. Moor holds an MD from the University of Basel and a PhD from ETH Zurich's Machine Learning and Computational Biology Lab under Prof. Karsten Borgwardt. Research Interests: Generalist medical AI models Multimodal medical reasoning Zero-shot and few-shot learning Clinical causal inference Retrieval-augmented language models Sepsis prediction systems Key Achievements: Published foundational work in Nature (2023) on generalist medical AI Developed Med-Flamingo multimodal model (2023) Zero-shot causal learning framework accepted to NeurIPS 2023 (Spotlight) International sepsis prediction study with 156k ICU patients (2023) Lab Activities: Leads ETH's Medical Foundation Models group, collaborating with Stanford HAI and NASA Ames. Active in creating medical AI benchmarks like AgentClinic and developing retrieval-augmented systems like Almanac.

Nagi GebraeelView profile

Professor

• Predictive Analytics
• Machine Learning
• Prognostics and Health Management
• +5 more

Professor Nagi Gebraeel serves as the Georgia Power Early Career Professor in the H. Milton Stewart School of Industrial and Systems Engineering at Georgia Institute of Technology, where his research integrates predictive analytics, machine learning, and optimization for industrial IoT applications. His work focuses on real-time equipment diagnostics, prognostics, and operational decision-making in critical infrastructure systems. Education: Ph.D. in Industrial Engineering (2003), Purdue University M.S. in Industrial Engineering (1998), Purdue University Research Focus: Dr. Gebraeel develops statistical learning algorithms for IoT-enabled maintenance, repair, and operations (MRO), with emphasis on federated learning frameworks for distributed fault diagnosis and cybersecurity protection against Industrial Control System (ICS) attacks. His research spans manufacturing, power generation, and deep space habitats through NASA's HOME Space Technology Research Institute, where he pioneers self-aware habitat systems. Recent work addresses data heterogeneity in high-consequence industrial environments using causal-informed analytics. Publication Trends: His 2024-2025 publications demonstrate a strong trajectory toward distributionally robust optimization for maintenance logistics, federated learning architectures for distributed fault diagnosis, and prognostics for complex systems like offshore wind farms and industrial robots. Key themes include handling imbalanced data in fault diagnosis, state-space representations for interdependent systems, and cybersecurity integration in manufacturing networks. Awards and Recognition: NSF CAREER Award (2007) SAE Aircraft Electrical Power System Recognition Award (2008) SAE Materials Modeling and Testing Recognition Award (2006) IEEE-AUTOTESTCON Certificate (2006) Fellow of the Institute of Industrial and Systems Engineers Advising and Funding: Dr. Gebraeel mentors doctoral students including Michael Ibrahim (2025 IISE Best Student Paper winner), Heraldo Rozas (now Assistant Professor at University of Chile), Ayush Mohanty, and Nazal Mohamed. He secured a $500,000 NSF grant in August 2025 for AI-driven cybersecurity in distributed manufacturing networks and leads NASA-funded research on deep space habitat systems. His work bridges academic research with industry applications through Georgia Tech's Strategic Energy Institute collaborations. Research Infrastructure: He directs the Analytics and Prognostics Systems laboratory at Georgia Tech's Manufacturing Institute and leads the Predictive Analytics and Intelligent Systems (PAIS) research group. Previously, he served as associate director of Georgia Tech's Strategic Energy Institute (2014-2019), fostering data science applications in energy systems.

Sanjay PurushothamView profile

Assistant Professor

• Machine Learning
• Data Mining
• Optimization Theory
• +5 more

Sanjay Purushotham is an Assistant Professor in the Department of Information Systems at the University of Maryland Baltimore County (UMBC), with a PhD in Electrical Engineering from the University of Southern California (USC) and a postdoctoral background in Computer Science at USC's Integrated Media Systems Center (IMSC). His research focuses on machine learning, data mining, and their applications in biomedical informatics, social network analysis, and multimedia data mining. Key contributions include survival analysis models using pseudo values and federated learning frameworks for healthcare data. He has received awards including the Best Paper Award at SIGSPATIAL 2014 and a Best Poster Runnerup at SCMLS 2016. Education: PhD in Electrical Engineering (USC), Postdoc in Computer Science (USC) His work spans interdisciplinary areas such as domain adaptation for remote sensing, thermal face translation, and interpretable neural networks for medical applications. Recent projects include federated survival analysis models and climate-informatics frameworks for cloud property retrieval. He teaches courses in artificial intelligence, healthcare informatics, and statistical learning at UMBC. Research highlights include developing MedFuseNet for multimodal medical question answering and VDAM for multi-sensor cloud data analysis. His work on fair survival analysis models addresses algorithmic bias in healthcare predictions. Current grants include a NSF CAREER award for trustworthy federated learning in computational healthcare.

Aria FallahView profile

Assistant Professor

• Evidence-Based Surgery
• Clinical Trials
• Pediatric Epilepsy Surgery
• +7 more

Dr. Aria Fallah, MD, is an Assistant Professor in Neurosurgery at the University of California, Los Angeles (UCLA), with secondary appointments in Health Policy and Management. His research focuses on Evidence-Based Surgery , Clinical Trials , and Meta-Analyses for pediatric epilepsy surgery outcomes, including prognostic tools and comparative effectiveness studies . He actively participates in international collaborations like the CTSI and has published extensively in journals such as Epilepsia , Neurology , and Clinical Neurophysiology . University: University of California, Los Angeles Department: Neurosurgery Email: afallah@mednet.ucla.edu Dr. Fallah’s research integrates machine learning and deep learning to analyze high-frequency oscillations in epilepsy, aiming to refine diagnostic and therapeutic strategies. His recent work includes developing tools like PyHFO for oscillation detection and HOPS calculator for predicting seizure freedom after hemispherectomy. His publications highlight collaborations across institutions in pediatric epilepsy surgery , hemimegalencephaly , and thalamic neuromodulation . While no explicit awards or student advisement are listed, his contributions span clinical trials , neuroimmunology , and global neurosurgery initiatives , including work in Haiti.